Paper42529751
Outcomes of Helicobacter Pylori eradication on lipid profiles and cardiovascular disease risk: a systematic review, meta-analysis, and meta-regression.
Sukmagautama C and 9 others. Gastroenterol Hepatol Bed Bench, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Outcomes of Helicobacter Pylori eradication on lipid profiles and cardiovascular disease risk: a systematic review, meta-analysis, and meta-regression. Papers, record 42529751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42529751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Outcomes of Helicobacter Pylori eradication on lipid profiles and cardiovascular disease risk: a systematic review, meta-analysis, and meta-regression.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16004885 | Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. | Int J Cardiol | 2005 | https://conductscience.org/library/papers/16004885 | PubMed |
| 2 | 21357376 | Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. | Cancer Epidemiol Biomarkers Prev | 2011 | https://conductscience.org/library/papers/21357376 | PubMed |
| 3 | 30705518 | Eradication therapy for Helicobacter pylori infection improves nutrition status in Japanese hemodialysis patients: a pilot study. | J Clin Biochem Nutr | 2019 | https://conductscience.org/library/papers/30705518 | PubMed |
| 4 | 35770660 | Long-term Effects of the Eradication of Helicobacter pylori on Metabolic Parameters, Depending on Sex, in South Korea. | Gut Liver | 2023 | https://conductscience.org/library/papers/35770660 | PubMed |
| 5 | 38176660 | Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022. | Gastroenterology | 2024 | https://conductscience.org/library/papers/38176660 | PubMed |
| 6 | 40385059 | Predictive value of lipid levels in coronary heart disease in elderly hypertensive patients. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/40385059 | PubMed |
| 7 | 33668848 | The Effect of Helicobacter pylori Eradication on Lipid Levels: A Meta-Analysis. | J Clin Med | 2021 | https://conductscience.org/library/papers/33668848 | PubMed |
| 8 | 29293574 | Association between Helicobacter pylori eradication and the risk of coronary heart diseases. | PLoS One | 2018 | https://conductscience.org/library/papers/29293574 | PubMed |
| 9 | 15702858 | Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. | Dig Liver Dis | 2005 | https://conductscience.org/library/papers/15702858 | PubMed |
| 10 | 20389238 | Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. | Coron Artery Dis | 2010 | https://conductscience.org/library/papers/20389238 | PubMed |
| 11 | 36974892 | Helicobacter pylori infection and risk of cardiovascular disease. | Helicobacter | 2023 | https://conductscience.org/library/papers/36974892 | PubMed |
| 12 | 20134372 | Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. | South Med J | 2010 | https://conductscience.org/library/papers/20134372 | PubMed |
| 13 | 33508177 | Eradication of Helicobacter pylori infection decreases risk for dyslipidemia: A cohort study. | Helicobacter | 2021 | https://conductscience.org/library/papers/33508177 | PubMed |
| 14 | 29291198 | Effect of Helicobacter pylori eradication on elder cases: Observational study in community-based medicine. | World J Clin Cases | 2017 | https://conductscience.org/library/papers/29291198 | PubMed |
| 15 | 37417262 | Effect of Helicobacter pylori Eradication on Body Weight: A Multicenter Propensity Score-matched Analysis in Korea. | J Neurogastroenterol Motil | 2023 | https://conductscience.org/library/papers/37417262 | PubMed |
| 16 | 40276821 | Effect of Helicobacter pylori Eradication on Metabolic Parameters and Body Composition including Skeletal Muscle Mass: A Matched Case-Control Study. | Gut Liver | 2025 | https://conductscience.org/library/papers/40276821 | PubMed |
| 17 | 20652370 | Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. | Eur J Epidemiol | 2010 | https://conductscience.org/library/papers/20652370 | PubMed |
| 18 | 33782057 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | BMJ | 2021 | https://conductscience.org/library/papers/33782057 | PubMed |
| 19 | 39626064 | ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. | Am J Gastroenterol | 2024 | https://conductscience.org/library/papers/39626064 | PubMed |
| 20 | 11966548 | Eradication of Helicobacter pylori infection induces an increase in body mass index. | Aliment Pharmacol Ther | 2002 | https://conductscience.org/library/papers/11966548 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42529751
GET https://conductscience.org/api/papers/v1/42529751/references?page=2